VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 222 filers reported holding VERACYTE INC in Q4 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,281,580 | -12.7% | 684,352 | -0.5% | 0.00% | -20.0% |
Q2 2023 | $17,512,128 | +20.4% | 687,559 | +5.4% | 0.01% | +25.0% |
Q1 2023 | $14,547,472 | -6.0% | 652,353 | +0.0% | 0.00% | -20.0% |
Q4 2022 | $15,477,560 | +45.6% | 652,236 | +1.8% | 0.01% | +25.0% |
Q3 2022 | $10,633,000 | -1.0% | 640,508 | +18.7% | 0.00% | 0.0% |
Q2 2022 | $10,737,000 | -23.4% | 539,513 | +6.2% | 0.00% | 0.0% |
Q1 2022 | $14,008,000 | -32.8% | 508,066 | +0.5% | 0.00% | -33.3% |
Q4 2021 | $20,836,000 | -9.1% | 505,712 | +2.5% | 0.01% | -14.3% |
Q3 2021 | $22,925,000 | +21.2% | 493,530 | +4.3% | 0.01% | +16.7% |
Q2 2021 | $18,913,000 | -25.5% | 473,046 | +0.1% | 0.01% | -33.3% |
Q1 2021 | $25,391,000 | +30.0% | 472,387 | +18.4% | 0.01% | +12.5% |
Q4 2020 | $19,533,000 | +54.6% | 399,103 | +2.6% | 0.01% | +33.3% |
Q3 2020 | $12,634,000 | +47.3% | 388,842 | +17.4% | 0.01% | +50.0% |
Q2 2020 | $8,578,000 | -2.6% | 331,176 | -8.6% | 0.00% | -20.0% |
Q1 2020 | $8,805,000 | -21.0% | 362,166 | -9.3% | 0.01% | -16.7% |
Q4 2019 | $11,148,000 | +13.6% | 399,262 | -2.4% | 0.01% | 0.0% |
Q3 2019 | $9,817,000 | +55.3% | 409,020 | +84.4% | 0.01% | +50.0% |
Q2 2019 | $6,323,000 | +52.1% | 221,763 | +33.5% | 0.00% | +33.3% |
Q1 2019 | $4,157,000 | +188.9% | 166,111 | +45.3% | 0.00% | +200.0% |
Q4 2018 | $1,439,000 | +38.4% | 114,349 | +5.0% | 0.00% | 0.0% |
Q3 2018 | $1,040,000 | -21.7% | 108,877 | -23.5% | 0.00% | 0.0% |
Q2 2018 | $1,329,000 | +43.2% | 142,283 | -14.7% | 0.00% | 0.0% |
Q1 2018 | $928,000 | -14.9% | 166,876 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,090,000 | -23.6% | 166,876 | +2.7% | 0.00% | 0.0% |
Q3 2017 | $1,426,000 | +276.3% | 162,562 | +258.1% | 0.00% | – |
Q2 2017 | $379,000 | +77.9% | 45,400 | +95.7% | 0.00% | – |
Q1 2017 | $213,000 | +18.3% | 23,200 | 0.0% | 0.00% | – |
Q4 2016 | $180,000 | +1.7% | 23,200 | 0.0% | 0.00% | – |
Q3 2016 | $177,000 | +51.3% | 23,200 | 0.0% | 0.00% | – |
Q2 2016 | $117,000 | -7.1% | 23,200 | 0.0% | 0.00% | – |
Q1 2016 | $126,000 | -25.0% | 23,200 | 0.0% | 0.00% | – |
Q4 2015 | $168,000 | +54.1% | 23,200 | 0.0% | 0.00% | – |
Q3 2015 | $109,000 | -37.0% | 23,200 | +49.7% | 0.00% | – |
Q2 2015 | $173,000 | – | 15,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |